After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Monte Rosa Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Monte Rosa Therapeutics Inc is $357.56M. A total of 0.7 million shares were traded on the day, compared to an average of 2.95M shares.
In the most recent transaction, Versant Venture Capital VI, L. sold 89,990 shares of GLUE for 9.66 per share on Oct 28 ’24. After the transaction, the 10% Owner now owns 2,007,948 company shares. In a previous transaction on Oct 29 ’24, Versant Venture Capital VI, L. sold 67,905 shares at 9.16 per share. GLUE shares that 10% Owner owns now total 1,573,453.
Among the insiders who bought shares, Wallace Owen B. acquired of 20,000 shares on Oct 28 ’24 at a per-share price of $12.00. In another insider transaction, Versant Venture Capital VI, L. sold 1,132,566 shares at $6.53 per share on Sep 20 ’24. Company shares held by the 10% Owner now total 5,099,336.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, GLUE has a high of $12.40 and a low of $3.21.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. GLUE’s latest balance sheet shows that the firm has $346.07M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $16.64M in liabilities at the time. Its Book Value Per Share was $3.35, while its Total Shareholder’s Equity was $347.51M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GLUE is Buy with a score of 4.71.
